Showing results (271-280 of 295) with videos related to

Sort By:
Pageof 30
The New England Journal of Medicine|December 12, 2019
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast CancerRashmi K Murthy, Sherene Loi, Alicia Okines, et al.
Neurology|February 28, 2020
Disease modification and biomarker development in Parkinson disease: Revision or reconstruction?Alberto J Espay, Lorraine V Kalia, Ziv Gan-Or, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2017
Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Nonamplified Metastatic Breast CancerCynthia X Ma, Ron Bose, Feng Gao, et al.
NPJ Precision Oncology|February 13, 2026
Clinical validation of a tissue-agnostic genome-wide methylome enrichment assay to monitor response to pembrolizumabEric Y Stutheit-Zhao, Yongqi Zhong, Collin A Melton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2025
Randomized Phase II Study of Bevacizumab with Weekly Anetumab Ravtansine or Weekly Paclitaxel in Platinum-Resistant/Refractory High-Grade Ovarian Cancer (NCI Trial)Husam A Alqaisi, David E Cohn, Jing-Yi Chern, et al.
Nature Communications|January 3, 2026
Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations: results from the Phase II BEAVER trialApril A N Rose, Jennifer Maxwell, Emmanuelle Rousselle, et al.
European Journal of Cancer (Oxford, England : 1990)|September 16, 2019
Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumoursRobin L Jones, Mark J Ratain, Peter J O'Dwyer, et al.
Cancer Discovery|January 12, 2020
Characteristics and Outcome of AKT1 E17K-Mutant Breast Cancer Defined through AACR Project GENIE, a Clinicogenomic RegistryLillian M Smyth, Qin Zhou, Bastien Nguyen, et al.
Nature Communications|June 24, 2022
Results of the phase I CCTG IND.231 trial of CX-5461 in patients with advanced solid tumors enriched for DNA-repair deficienciesJohn Hilton, Karen Gelmon, Philippe L Bedard, et al.
Genome Medicine|October 27, 2016
Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trialTracy L Stockley, Amit M Oza, Hal K Berman, et al.
Pageof 30